Status of Lipid Profile in Hypertensive Patients of A, B, O and AB Blood Groups

  • Shalini Arora Lecturer, Department of Biochemistry, Rama Dental College Hospital & Research Centre Kanpur
  • Tariq Mahmood Associate professor, Dept. Of Biochemistry, Shri Ram Murti Smarak Institute of Medical Sciences, Bareilly.
  • Gaura Dadheech Assistant professor, Dept. of Biochemistry, Jawahar Lal Nehru Medical college, Ajmer
  • Ramesh Chandra Gupta Professor and HOD, Dept. of Biochemistry, National Institute of Medical Sciences, Jaipur.
Keywords: Biochemical markers, Percutaneous coronary intervention, Risk of myocardial damage, Surface ECG


Background: Hypertension is the most common illness of circulatory system and is a worldwide health challenge affecting both developed and developing nations. The development of hypertension is a multi-factorial process and the risk factors for its development are many such as genetic factors, obesity, age & sex factors, salt sensitivity, dyslipidemia, hyperinsulinemia & insulin resistance, environmental factors, socio economic imbalances, free radicals/reactive Oxygen species, oxidative stress, blood groups etc. The role of blood groups in the etiology of essential hypertension has long been suspected.

Methods: The study design was a cohort study consisting of 15 hypertensive patients of the A, B, AB and O each. Anthropometric parameters such as Blood pressure (SBP/DBP) and Body Mass Index (BMI) and Biochemical parameters such as Blood grouping, Blood Glucose levels, Haemoglobin levels, Lipid profile, which included Triglycerides, Total cholesterol, HDL cholesterol and LDL and VLDL cholesterol, were measured using standardized methods. The various parameters were compared between hypertensives of the various blood groups and statistical analysis was done using SPSS. Mean and SD of each group was calculated, and Unpaired student’s t-test was applied (P < 0.05 considered as significant).

Results: When BMI was compared among hypertensive groups we observed significant increased level of BMI in group A as compared to group O hypertensives. (10.36%; P<0.05). While comparing SBP between hypertensive groups we observed significant raised level of SBP in group A as compared to group B (9.38%; P<0.01) and O (10.45%; P<0.01). Similarly, DBP was found to be increased significantly in group A as compared to group B ((5.34%; P<0.05) and O hypertensive patients (5.06%; P<0.001). LDL-C and HDL-C were non-significantly altered in these groups however value of VLDL-C was found increased in group A as compared to group O hypertensives (20.38%; P< 0.05). Conclusion: The study concluded that there is a significantly higher SBP and DBP in the hypertensives of the A blood group as compared to the hypertensives of the B and O blood groups. It also found increased levels of serum triglycerides, total cholesterol, LDL-C, VLDL-C along with decreased levels of HDL-C was in hypertensive patients predominantly in group A and AB hypertensive. The hypertensive patients of A blood group have shown a statistically significant increase in BMI as compared to hypertensives of the other blood groups.


Download data is not yet available.


1) Falkner B, Lurbe E, Schaefer F (2010). High Blood pressure in children: Clinical and health policy implications. Journal of Clinical Hypertension 12(4): 261-76
2) Kumar A, Nagtilak S, Sivakanesan R, Gunasekera S. (2009) Cardiovascular risk factors in elderly normolipidemic acute myocardial infarct patients. A case-controlled study from India. Southeast Asian J Trop Med Public Health 40 (3):581-591.
3) Gupta R, Gupta S. (2017). Hypertension in India:Trends prevalence, awareness, treatment and control. RUHS Journal of health sciences 2(1): 40-46.
4) Watkins WM (1967). Gene-enzyme relationships of the A, B, H and Le blood group genes (abstracts.) Transfusion 7: 367.
5) Storry JR, Olsson ML (2009). The ABO blood group system revisited: a review and update. Immunohaematology 25 (2): 48-57.
6) Patenaude SI, Seto NO, Borisova SN et al (2002). The structural basis for specificity in human ABO (H) blood group biosynthesis. National Structural Biology 9: 685-90.
7) Takasaki S, Yamashita K, Kobata A (1978). The sugar chain structure of ABO blood group active glycoproteins obtained from human erythrocyte membrane. The Journal of Biological Chemistry 253 (17): 6086-6091.
8) Horby J, Ceyrtrup JZ, Grande P, Vestergaard A (1989). Relation of serum lipoproteins and lipids to the ABO blood groups in patients with intermittent claudication. Journal of Cardiovascular Surgery 30(4): 533- 537.
9) Tarjan Z, Tonelli M, Duba J, Zorandi A (1995) Correlation between ABO and Rh blood groups, serum cholesterol and ischaemic heart disease in patients undergoing coronarography. Orvosi Hetilop 136(15) :767-769.
10) Meade TW, Copper JA, Sterling Y, Howarth DJ, Ruddock V, Miller GJ (1994). Factor VIII, ABO blood group and the incident of ischaemic heart disease. British Journal of Haematology 88(3): 601-607.
11) Wong FL, Kodama K, Sasaki H, Yamada M, Hamilton HB (1992). Longitudinal study of the association between ABO phenotype and total serum cholesterol level in a Japanese cohort. Genetic Epidemiology 9(6): 405-418.
12) Gillium RF (1991). Blood groups, Serum cholesterol, serum uric acid, blood pressure and obesity in adolescents. Journal of National Medical Association 836(8): 682-688.
13) George VT, Flston RC, Amor CI, Ward L J, Berenson GS. (1987). Association between polymorphic blood markers and risk factors for cardiovascular disease in a large pedigree. Genetic Epidemiology 4(4): 267-75.
18) 19)
20) 21)
22) 23) 24) 25) 26) 27)
28) 29) 30) 31) 32) 33)
Wu O, Bayoum N, Vickers MA, Clark P. (2008). ABO (H) blood groups and vascular disease a systematic review and metaanlaynsis. Journal of Thrombosis and Haemostasis 6(1): 62-69.
Reid M E (2009). MNS blood group system: a review. Immunohematology 25(3):95-101.
Clark P, Wu O (2011). ABO blood groups and thrombosis: a casual association but is there value in screening. Future Cardiol 7: 191-201. Dacie and Lewis (2001). In: Practical Haematology,9th Ed., (Churchill Livingstone, UK) p472-475.
Drabkin DL et al (1932). Journal of Biochemistry 98: 719.
Trinder P (1969) Determination of serum cholesterol by enzymatic colorimetric method. Annals of Clinical Biochemistry 6: 24-27. Roeschalu P, Bernt E, Gruber WA (1974). Clinical Chemistry Clinical Biochemistry 12(226)
Brustein M, Scholinck HR, Morfin R (1970) Rapid Method for the isolation of lipoproteins from human serum by precipitation with polyanions. Journals of Lipid Research 11:583.
Friedewald WT, Levy RI, Fridrickson DS (1972). Estimation of the concentrations of low-density lipoprotein cholesterol in plasma without use of the preparative ultra-centrifuge 18 :499-502.
Contiero E, Chinello GE, Folin M. (1994). Serum Lipid and lipoproteins associations with ABO blood groups. Anthropologischer Anzeiger 52(3): 221-30.
Biswas KU, Kumar A (2010). A study on lipid profile, oxidative stress and carbonic anhydrase activity in patients with essential hypertension. Journal of Clinical and Diagnostic Research 4:3414-3420.
Kumar LN, Deepthi J, Rao YN, Deedi kiran M. (2010). Study of lipid profile, serum magnesium and blood glucose in hypertension. Biology and Medicene 2(1):6-16.
Saha MS, Sana NK, Saha RK (2006). Serum lipid profile of hypertensive patients in the northern region of Bangladesh. Journal of Biosciences 14: 93-98.
Lithell H, Lindgard F, Hellsing K, Lundqvist G, Nygaard E, Vessby B, Saltin B. (1981). Body weight, Skeletal muscle morphology, and enzymes activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men. Diabetes 30: 19-25.
Bayer PM, Hotschek H, Knoth E (1980). Intestinal alkaline phosphatase and the ABO blood group system- a new aspect. Clinica Chimica Acta 108(1): 81-87.
Nakata N, Tozawa T (1995) The ABO blood groups dependent reference intervals for serum alkaline phosphates isoenzyme total activity in individuals 20-39 years of age. Rinsho Byori 43(5): 508-512 Domar U, Hiran K, Stigbrand T (1991). Serum levels of human alkaline phosphatase isoenzymes in relations to blood groups. Clinica Chimica Acta 203(2-3): 305-313.
White CR, BrockTA, Chang LY (1994). Superoxide and peroxynitrite in atherosclerosis. Proceeding of National Academy of Sciences of the United states of America 91: 1044-1048.
Morrel DW, DI Corleto PE, Chisolin GM (1984). Endothelial and Smooth Muscle cells alter low density lipoprotein in Vitro by fratricidal oxidation 4: 357-364.
Assadpoor-Piranfar M, Pordal HA, Beyranvand RM (2009). Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Archives of Iranian Medicine 12(2): 116-120.
How to Cite
Arora S, Mahmood T, Dadheech G, Gupta R. Status of Lipid Profile in Hypertensive Patients of A, B, O and AB Blood Groups. IABCR [Internet]. 29Dec.2018 [cited 23Jan.2019];4(4):30-4. Available from: